Last reviewed · How we verify
FICB Block
At a glance
| Generic name | FICB Block |
|---|---|
| Sponsor | Pain Medicine Department |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery (NA)
- Comparison of Supra vs Infra Inguinal Fascia Iliaca Blocks for Spinal Positioning and Analgesia in Lower Limb Surgery (PHASE2, PHASE3)
- Pericapsular Nerve Group Block vs Supra Inguinal Fascia Iliaca Compartment Block (NA)
- Comparing Erector Spinae and Fascia Iliaca Blocks for Pain Relief After Femur Surgery. (NA)
- Analgesic Efficacy of Fascia Iliaca Compartment Block Compared With Intrathecal Nalbuphine for Hip Surgery Under Spinal Anesthesia (NA)
- Comparison of EOSP Between Usg Guided S-FICB vs USG Guided PENG Block in Pts Undergoing Femur Fracture Surgery (PHASE2, PHASE3)
- Pericapsular Nerve Group Block vs. Fascia Iliaca Compartment Block vs. Caudal Block for Hip Surgeries (NA)
- PENG Block in Comparison With FICB for Hip Reconstruction in Children (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FICB Block CI brief — competitive landscape report
- FICB Block updates RSS · CI watch RSS
- Pain Medicine Department portfolio CI